Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 149

Results For "CEP"

1785 News Found

HaystackAnalytics sees alarming rise in TB cases
Healthcare | March 24, 2022

HaystackAnalytics sees alarming rise in TB cases

A staggering 65% of the TB cases in India are in the 15-45 age group


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


Johnson & Johnson India launches ‘Be The Change For TB’ initiative
Public Health | March 24, 2022

Johnson & Johnson India launches ‘Be The Change For TB’ initiative

#BeTheChangeForTB is a public awareness initiative under the Corporate TB Pledge and aims to create a cadre of Youth Changemakers who can act as catalysts of change to help eliminate TB from India


USFDA approves Novartis Pluvicto to treat prostrate cancer
Drug Approval | March 24, 2022

USFDA approves Novartis Pluvicto to treat prostrate cancer

USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions


Study shows green Mediterranean diet modifies bacterial population in gut
Biotech | March 23, 2022

Study shows green Mediterranean diet modifies bacterial population in gut

The study was published recently in Genome Medicine, a leading international journal focused on translational, genomic-based medicine


Arum Therapeutics implements CDD Vault to streamline research data
Biotech | March 23, 2022

Arum Therapeutics implements CDD Vault to streamline research data

Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers


Pfizer voluntary recall of drugs in the US
News | March 23, 2022

Pfizer voluntary recall of drugs in the US

Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Trivitron Healthcare elevates Chandra Ganjoo to Group CEO
People | March 22, 2022

Trivitron Healthcare elevates Chandra Ganjoo to Group CEO

She joined Trivitron Healthcare in 1999 and has held several positions in the organisation


Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health
News | March 22, 2022

Boehringer Ingelheim and the World Association for Buiatrics support research on ruminant animal health

Submissions for Ruminant Well-Being Awards and Gustav Rosenberger Memorial Fund grant open now